SCHEMBL570244

SCHEMBL570244

Oc1[c]c2nn[nH]c2cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10468266 0.75
SCHEMBL16670900 0.73
SCHEMBL9286289 0.73 HCAR2 (0.33)
SCHEMBL10467385 0.71
SCHEMBL8531906 0.67
SCHEMBL5551815 0.66 NISCH (0.37)
SCHEMBL242787 0.64 ALDH1A1 (0.48)
SCHEMBL9171831 0.62 ALDH1A1 (0.47)
Benzotriazole SCHEMBL29754639 0.61 ALDH1A1 (0.33)
Benzotriazole SCHEMBL28954700 0.60 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3193941-A1 PRODRUGS COMPRISING AN AMINOALKYL GLYCINE LINKER Ascendis Pharma A/S (DK) 2017-07-26 EP claimed
US-9695189-B2 Chemical crosslinkers and compositions thereof Nguyen, Mark Quang (US) 2017-07-04 US claimed
US-20160143937-A1 METHODS OF USING CLEAVABLE DRUG CONJUGATES AND COMPOSITIONS THEREOF Nguyen, Mark Quang (US) 2016-05-26 US claimed
US-9295731-B2 Cleavable drug conjugates, compositions thereof and methods of use Nguyen, Mark Quang (US) 2016-03-29 US claimed
WO-2016020373-A1 PRODRUGS COMPRISING AN AMINOALKYL GLYCINE LINKER ASCENDIS PHARMA A/S (DK) 2016-02-11 WO claimed
US-20140294851-A1 CLEAVABLE DRUG CONJUGATES, COMPOSITIONS THEREOF AND METHODS OF USE Nguyen, Mark Quang (US) 2014-10-02 US claimed
US-20140249319-A1 CHEMICAL CROSSLINKERS AND COMPOSITIONS THEREOF Nguyen, Mark Quang (US) 2014-09-04 US claimed
WO-2006066258-A2 LIPOCONJUGATION OF PEPTIDES NEOSE TECHNOLOGIES, INC. (US) 2006-06-22 WO claimed
EP-0609899-A1 Derivatives of amino-ascorbic acid,the processes for their preparation and use PLIVA FARMACEUTSKA KEMIJSKA PREHRAMBENA I KOZMETICKA INDUSTRIJA DIONICKO DRUSTVO ZAGREB (HR) 1994-08-10 EP claimed
US-4089868-A Sulfonium salt substantive sunscreen materials COLGATE-PALMOLIVE COMPANY (US) 1978-05-16 US claimed
US-4022829-A INTERMEDIATES FOR SUNSCREEN AGENTS COLGATE-PALMOLIVE COMPANY (US) 1977-05-10 US claimed
EP-3864068-A2 METHOD OF MAKING RELEASABLE POLYMERIC REAGENTS Nektar Therapeutics (US) 2021-08-18 EP disclosed
US-10898503-B2 Cleavable drug conjugates, compositions thereof and methods of use Nguyen, Mark Quang (US) 2021-01-26 US disclosed
US-9708370-B2 Azapeptides as CD36 binding compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2017-07-18 US disclosed
US-9695189-B2 Chemical crosslinkers and compositions thereof Nguyen, Mark Quang (US) 2017-07-04 US disclosed
EP-0429611-A1 AMINOALKYL MALEIMIDES AND HAPTENE AND ANTIGEN DERIVATIVES THEREOF AND CONJUGATES WITH PEPTIDES OR PROTEINS Roche Diagnostics GmbH (DE) 1991-06-05 EP disclosed
WO-1990015798-A1 AMINOALKYL MALEIMIDES AND HAPTENE AND ANTIGEN DERIVATIVES THEREOF AND CONJUGATES WITH PEPTIDES OR PROTEINS BOEHRINGER MANNHEIM GMBH (DE) 1990-12-27 WO disclosed
WO-1990010718-A1 SEQUENCING NUCLEIC ACIDS USING CHEMILUMINESCENT DETECTION MILLIPORE CORPORATION (US) 1990-09-20 WO disclosed
US-4888385-A BENZOTRIAZOLYLOXYTRIS/DIMETHYLAMINO/PHOSPHONIUM HEXAFLUOROPHOSPHATE AND HYDROXYBENZOTRIAZOLE ACTIVATOR MILLIPORE CORPORATION (US) 1989-12-19 US disclosed
EP-0289353-A2 Modified BOP reagent for solid phase peptide synthesis MILLIPORE CORPORATION (US) 1988-11-02 EP disclosed